Microcap Ledger

Tickers · $UTMD

Utah Medical Products Inc $UTMD

By Microcap Ledger desk · CIK 0000706698

Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.

Snapshot

Exchange
Nasdaq Global Select Market
Sector
Surgical & Medical Instruments & Apparatus
Headquarters
Midvale, UT
Fiscal year end
December 31
Shares outstanding
3,183,818 [10-Q 2026-08-12]
as of 2026-08-11

Sources: [10-K 2026-03-27]

What the company doesAI summary of filing

Utah Medical Products, Inc. manufactures and sells medical devices focused on patient safety and improved clinical outcomes, primarily for use in neonatal intensive care units, labor and delivery departments, women's health centers, and outpatient clinics. The company is revenue-generating, deriving income from direct sales to hospitals and clinical end-users in the United States and internationally, sales through medical device distributors, and original equipment manufacturer (OEM) work producing components and finished devices for other companies. Domestically, UTMD sells through its own sales force and designated stocking distributors; outside the U.S., it distributes directly to end-users in Canada, the UK, France, Ireland, Australia, and New Zealand, and through approximately 200 independent regional distributors in other countries. Products acquired through acquisitions comprised 57% of consolidated 2025 sales. [10-K 2026-03-27]

Segments: Labor and Delivery/Obstetrics, Neonatal Intensive Care, Gynecology/Urology/Electrosurgery, Pressure Monitoring

Financial health

From XBRL company facts (USD)
PeriodRevenueNet incomeOperating cash flowCashFiling
6 months to Jun 2026$17.25M$5.29M $4.49M$87.53M[10-Q 2026-08-12]
FY ended Dec 2025$38.52M$11.29M $14.69M$85.76M[10-K 2026-03-27]
FY ended Dec 2024$40.90M$13.87M $14.83M$82.98M[10-K 2026-03-27]

Capital structure and dilution

Summary only. How these instruments work: Dilution & financing desk.

Share count
DateShares outstandingFiling
2024-11-113,391,620[10-Q 2024-11-12]
2025-03-253,281,816[10-K 2025-03-26]
2025-05-123,248,210[10-Q 2025-05-15]
2025-08-113,205,723[10-Q 2025-08-12]
2025-11-103,203,672[10-Q 2025-11-14]
2026-03-263,185,025[10-K 2026-03-27]
2026-05-113,184,025[10-Q 2026-05-12]
2026-08-113,183,818[10-Q 2026-08-12]

Listing status

Current status: No Form 8-K Item 3.01 (listing notice) filings in the last 24 months, as of 2026-10-11.

More on deficiency notices and uplistings: Listing status desk.

Who owns it

Recent Form 4 transactions
DateInsiderTypeSharesPriceFiling
2026-06-29Richins Paul Oother150$73.07[4 2026-07-01]
2026-05-28Koopman Brianother50$66.27[4 2026-05-29]

Catalysts and calendar

Recent filings and releases
DateTypeTitle
2026-08-318-KRegulation FD disclosure
2026-08-1413G/ABeneficial ownership report (5%+ holder)
2026-08-1313G/ABeneficial ownership report (5%+ holder)
2026-08-1210-QQuarterly report
2026-07-238-KResults of operations
2026-05-1413G/ABeneficial ownership report (5%+ holder)
2026-05-1210-QQuarterly report
2026-05-048-KShareholder vote results
2026-04-238-KResults of operations
2026-04-02DEF 14AProxy statement
2026-03-2710-KAnnual report
2026-03-2713G/ABeneficial ownership report (5%+ holder)

Facts as of . Small caps move fast; check the latest filings.